drugset
drugset / Trial / NCT04865731

Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

NCT04865731 ↗

Phase 2 Completed 6 enrolled The University of Texas Health Science Center at San Antonio
RandomizedParallel-groupSingle-blindTreatment

Summary

In this study, the study team seek to conduct a pilot clinical study to evaluate the safety and efficacy of a reformulated proton pump inhibitor (PPI) cream (Dermaprazole) in definitive head and neck cancer (HNC) patients.

Timeline

Start
2022-06-15
Primary completion
2024-06-18
Completion
2024-06-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aquaphor Unknown 2 ml —
Subject Esomeprazole Small molecule 2 ml Topical

Indications

head and neck cancer